Please provide your email address to receive an email when new articles are posted on . Mean changes in eosinophilic gastritis histology total scores included –0.31 with treatment and –0.02 with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Allergens trigger the release of IL-18, which produces ...

If approved, Dupixent would be the first and only treatment in the U.S. indicated for children aged 1 to 11 with EoE, a disease driven by type 2 inflammation that impacts the ability to eat Of the ...

The treatment, Dupixent, was approved to treat eosinophilic esophagitis in adults and pediatric patients 12 and older weighing at least 88 pounds. Marc Rothenberg, MD, PhD, director of the Cincinnati ...

Credit: Takeda. The approval of Eohilia was based on data from 2 double-blind, parallel-group, placebo-controlled 12-week phase 3 trials. A statistically significantly greater proportion of patients ...

The Food and Drug Administration approved Dupixent as treatment for eosinophilic esophagitis in adults and children over the age of 12. In its announcement Friday afternoon, the FDA approved a 300 mg ...

Rationale To date, the exact significance of esophageal eosinophilia requires careful clinical consideration. Traditionally, this finding has been attributed solely to peptic injury, but with the ...

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a T-cell–mediated severe cutaneous adverse reaction characterized by rash, fever, internal organ involvement, and systemic ...

The U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Dupixent (dupilumab) to treat eosinophilic esophagitis patients 12 years and older. The efficacy and safety of Dupixent was ...

Go to source). Because it is rare and shares features with other conditions, many people may not immediately recognise its symptoms or know what to expect. Go to source). The condition is extremely ...

Eosinophilic fasciitis, or Shulman syndrome, is a rare condition that causes a painful thickening and stiffness in the connective tissue underneath the skin. This is known as the fascia. The condition ...